Biotech

All Articles

Actinogen reports new period 2 data to restore clinical depression drug

.Actinogen Medical's chances-- as well as inventory cost-- have actually recoiled a little coming fr...

Pfizer and Flagship add Ratio to multibillion-dollar equation

.Main Pioneering and Pfizer have actually added Quotient in to their 10-program relationship, inking...

Bayer markers $547M treaty to push boundaries of noncoding RNA

.Bayer managers were actually eager to stress to Ferocious this summer that the German pharma giant'...

UK introduces strategies to launch 18 brand new medical test centers

.In the middle of a yearslong scientific test decrease in the U.K., a new public-private alliance ha...

UPDATE: Genentech telegraphs 93 discharges in California after sharing programs to shutter cancer cells immunology research device

.Following the news of a sizable layoff shot in April and also a major rebuilding project unveiled e...

Neurocrine's KarXT rival attacks in phase 2-- yet merely at reduced dose

.Neurocrine Biosciences has attained its own hoped-for profile in a stage 2 mental illness test, del...

Vaderis' unusual blood vessel problem medication reduces nosebleeds

.Vaderis Therapies' target to build the very first medicine aimed primarily at a particular unusual ...

Navigator raises $100M to establish brand-new autoimmune pipe

.Navigator Medicines has equipped itself with $100 million in series A funds as the younger biotech ...

Duality looks for money for ADC trials as IPO wave infects Asia

.China's Duplicity Biotherapeutics has actually submitted (PDF) documentation for a Hong Kong IPO, l...

YolTech sells China legal rights to gene modifying treatment for $29M

.4 months after Chinese gene editing provider YolTech Therapeutics took its own cholesterol levels d...